<DOC>
	<DOCNO>NCT00316732</DOCNO>
	<brief_summary>This study design assess effectiveness dutasteride actual clinical practice prostate assessment clinic UK accordance best practice 12-month period .</brief_summary>
	<brief_title>Observational AVODART ( Dutasteride ) Study In Benign Prostatic Hyperplasia Subjects - OASIS</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Dutasteride</mesh_term>
	<criteria>Patients receive pharmacological treatment surgical intervention BPH ( Benign Prostatic Hyperplasia ) . Patients prescribed dutasteride compliance UK SmPC BAUS guideline treatment BPH . Patients must enter study decision prescribe dutasteride undertaken . Exclusion criterion : None specify</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Avodart</keyword>
	<keyword>IPSS</keyword>
	<keyword>BPH</keyword>
	<keyword>dutasteride</keyword>
	<keyword>EQ-5D</keyword>
	<keyword>Observational</keyword>
</DOC>